Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Sep 10, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | XFOR | X4 Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $337.1M | 1.47M | 1.57M | 93.6% |
| 2 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $11.57B | 203.1K | 229.9K | 88.3% |
| 3 | NNNN | Anbio Biotechnology | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $936.7M | 105.1K | 119.4K | 88.0% |
| 4 | KIDS | OrthoPediatrics Corp. | Health CareMedical/Dental Instruments | $562.9M | 332.8K | 379.8K | 87.6% |
| 5 | PCRX | Pacira BioSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.00B | 180.2K | 206.2K | 87.4% |
| 6 | PROK | ProKidney Corp. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $556.3M | 711.4K | 819.6K | 86.8% |
| 7 | GMED | Globus Medical Inc. | Health CareMedical/Dental Instruments | $9.88B | 641.1K | 739.8K | 86.7% |
| 8 | ZLAB | Zai Lab Limited | Health CareBiotechnology: Pharmaceutical Preparations | $2.71B | 512.4K | 594.4K | 86.2% |
| 9 | CNTN | Canton Strategic Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $171.3M | 204.8K | 237.6K | 86.2% |
| 10 | PTGX | Protagonist Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $9.39B | 144.9K | 170.6K | 84.9% |
| 11 | RDNT | RadNet Inc. | Health CareMedical Specialities | $5.85B | 249.4K | 295.4K | 84.4% |
| 12 | OVID | Ovid Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $513.6M | 502.8K | 595.8K | 84.4% |
| 13 | ORKA | Oruka Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $6.07B | 193.1K | 229.3K | 84.2% |
| 14 | SVRA | Savara Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.09B | 522.1K | 621.4K | 84.0% |
| 15 | PCVX | Vaxcyte Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.76B | 444.2K | 529.4K | 83.9% |
| 16 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $9.73B | 196.1K | 234.8K | 83.5% |
| 17 | RLMD | Relmada Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $434.1M | 1.34M | 1.61M | 83.3% |
| 18 | ANRO | Alto Neuroscience Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.24B | 368.8K | 443.3K | 83.2% |
| 19 | ILMN | Illumina Inc. | Health CareMedical Specialities | $30.39B | 404.9K | 492.9K | 82.2% |
| 20 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.72B | 193.0K | 235.1K | 82.1% |
| 21 | OCGN | Ocugen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $347.6M | 12.44M | 15.21M | 81.8% |
| 22 | EWTX | Edgewise Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.66B | 181.7K | 222.4K | 81.7% |
| 23 | LMAT | LeMaitre Vascular Inc. | Health CareMedical/Dental Instruments | $1.80B | 86.7K | 108.2K | 80.2% |
| 24 | RLX | RLX Technology Inc. | Health Care Medicinal Chemicals and Botanical Products | $2.18B | 634.1K | 793.5K | 79.9% |
| 25 | EYE | National Vision Holdings Inc. | Health CareOphthalmic Goods | $1.35B | 621.0K | 780.2K | 79.6% |
| 26 | ANL | Adlai Nortye Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $971.8M | 171.3K | 216.7K | 79.1% |
| 27 | STXS | Stereotaxis Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $130.3M | 269.5K | 340.9K | 79.1% |
| 28 | AMPH | Amphastar Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.00B | 130.3K | 165.1K | 78.9% |
| 29 | ALC | Alcon Inc. | Health CareOphthalmic Goods | $33.26B | 519.7K | 658.9K | 78.9% |
| 30 | DMRA | Damora Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.66B | 152.8K | 194.7K | 78.5% |
| 31 | ANIX | Anixa Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $93.6M | 147.4K | 188.1K | 78.4% |
| 32 | NVST | Envista Holdings Corporation | Health CareMedical/Dental Instruments | $4.16B | 600.7K | 772.9K | 77.7% |
| 33 | NVCR | NovoCure Limited | Health CareMedical/Dental Instruments | $1.79B | 493.1K | 636.3K | 77.5% |
| 34 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $4.31B | 115.3K | 149.0K | 77.4% |
| 35 | TYRA | Tyra Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.40B | 1.14M | 1.48M | 77.3% |
| 36 | HUMA | Humacyte Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $157.5M | 1.24M | 1.62M | 77.0% |
| 37 | DSGN | Design Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $926.2M | 197.0K | 257.7K | 76.5% |
| 38 | ASND | Ascendis Pharma A/S | Health CareBiotechnology: Pharmaceutical Preparations | $17.16B | 144.7K | 189.2K | 76.5% |
| 39 | SLN | Silence Therapeutics Plc | Health CareBiotechnology: Pharmaceutical Preparations | $622.9M | 247.3K | 323.8K | 76.4% |
| 40 | PRLD | Prelude Therapeutics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $372.7M | 172.8K | 226.3K | 76.4% |
| 41 | ARVN | Arvinas Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $569.5M | 272.5K | 359.8K | 75.7% |
| 42 | ESTA | Establishment Labs Holdings Inc. | Health CareIndustrial Specialties | $2.13B | 81.0K | 107.0K | 75.7% |
| 43 | RLAY | Relay Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.14B | 979.9K | 1.30M | 75.6% |
| 44 | AGEN | Agenus Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $310.2M | 229.1K | 303.1K | 75.6% |
| 45 | SIBN | SI-BONE Inc. | Health CareMedical/Dental Instruments | $820.2M | 271.3K | 359.1K | 75.5% |
| 46 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 366.4K | 485.4K | 75.5% |
| 47 | VCEL | Vericel Corporation | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.94B | 121.0K | 160.7K | 75.3% |
| 48 | AORT | Artivion Inc. | Health CareMedical/Dental Instruments | $1.20B | 121.8K | 162.0K | 75.2% |
| 49 | FDMT | 4D Molecular Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $745.2M | 124.4K | 165.6K | 75.1% |
| 50 | ABUS | Arbutus Biopharma Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $1.01B | 652.7K | 868.8K | 75.1% |
| 51 | CYH | Community Health Systems Inc. | Health CareHospital/Nursing Management | $407.5M | 238.6K | 317.7K | 75.1% |
| 52 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $24.99B | 585.0K | 779.1K | 75.1% |
| 53 | LUCD | Lucid Diagnostics Inc. | Health CareMedical/Dental Instruments | $163.4M | 585.4K | 784.9K | 74.6% |
| 54 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.03B | 195.9K | 263.0K | 74.5% |
| 55 | PALI | Palisade Bio Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $350.3M | 1.02M | 1.38M | 74.2% |
| 56 | MYGN | Myriad Genetics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $321.4M | 1.59M | 2.14M | 74.1% |
| 57 | ALNY | Alnylam Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $33.12B | 478.4K | 646.3K | 74.0% |
| 58 | HCA | HCA Healthcare Inc. | Health CareHospital/Nursing Management | $91.19B | 313.8K | 425.0K | 73.8% |
| 59 | SNDA | Sonida Senior Living Inc. | Health CareHospital/Nursing Management | $1.91B | 115.3K | 156.3K | 73.8% |
| 60 | ONC | BeOne Medicines Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $38.86B | 241.4K | 328.6K | 73.5% |
| 61 | LXRX | Lexicon Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $898.8M | 875.3K | 1.19M | 73.3% |
| 62 | GUTS | Fractyl Health Inc. | Health CareMedical/Dental Instruments | $102.4M | 283.3K | 386.8K | 73.2% |
| 63 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 64 | HSIC | Henry Schein Inc. | Health CareMedical Specialities | $9.73B | 258.1K | 352.8K | 73.2% |
| 65 | STAA | STAAR Surgical Company | Health CareOphthalmic Goods | $1.17B | 190.4K | 261.3K | 72.9% |
| 66 | ABEO | Abeona Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $313.4M | 733.3K | 1.01M | 72.8% |
| 67 | JAZZ | Jazz Pharmaceuticals plc | Health CareBiotechnology: Pharmaceutical Preparations | $15.61B | 243.0K | 334.9K | 72.6% |
| 68 | CGON | CG Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $6.38B | 158.7K | 218.8K | 72.5% |
| 69 | XRAY | DENTSPLY SIRONA Inc. | Health CareMedical/Dental Instruments | $2.09B | 1.02M | 1.41M | 72.4% |
| 70 | IBRX | ImmunityBio Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.18B | 2.95M | 4.07M | 72.4% |
| 71 | NRIX | Nurix Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.68B | 304.8K | 421.0K | 72.4% |
| 72 | HYPR | Hyperfine Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $83.4M | 85.9K | 118.8K | 72.3% |
| 73 | PACS | PACS Group Inc. | Health CareHospital/Nursing Management | $7.10B | 278.4K | 385.2K | 72.3% |
| 74 | ACHC | Acadia Healthcare Company Inc. | Health CareMedical Specialities | $2.66B | 320.9K | 444.4K | 72.2% |
| 75 | NEOG | Neogen Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.57B | 349.6K | 484.6K | 72.1% |
| 76 | ATYR | aTyr Pharma Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $42.4M | 383.5K | 533.0K | 71.9% |
| 77 | ACH | Accendra Health Inc. | Health CareMedical Specialities | $83.1M | 403.7K | 561.4K | 71.9% |
| 78 | SYRE | Spyre Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $7.82B | 208.7K | 290.6K | 71.8% |
| 79 | BDTX | Black Diamond Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $112.6M | 224.3K | 313.6K | 71.5% |
| 80 | QGEN | Qiagen N.V. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $8.68B | 232.2K | 325.7K | 71.3% |
| 81 | MPLT | MapLight Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $601.7M | 132.8K | 187.5K | 70.8% |
| 82 | PGNY | Progyny Inc. | Health CareMisc Health and Biotechnology Services | $2.08B | 194.1K | 274.9K | 70.6% |
| 83 | BTMD | Biote Corp. | Health Care Medicinal Chemicals and Botanical Products | $47.1M | 75.4K | 106.9K | 70.6% |
| 84 | TVTX | Travere Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.36B | 358.9K | 510.6K | 70.3% |
| 85 | GANX | Gain Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $74.6M | 230.1K | 327.5K | 70.3% |
| 86 | PHAT | Phathom Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $677.1M | 291.1K | 414.5K | 70.2% |
| 87 | ATRC | AtriCure Inc. | Health CareMedical/Dental Instruments | $2.69B | 241.8K | 345.1K | 70.1% |
| 88 | ARWR | Arrowhead Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $11.69B | 245.8K | 351.5K | 69.9% |
| 89 | VOR | Vor Biopharma Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.32B | 177.2K | 253.7K | 69.9% |
| 90 | DOMH | Dominari Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $48.7M | 106.9K | 153.1K | 69.8% |
| 91 | BKD | Brookdale Senior Living Inc. | Health CareHospital/Nursing Management | $2.91B | 1.44M | 2.07M | 69.7% |
| 92 | HRMY | Harmony Biosciences Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.39B | 201.9K | 290.0K | 69.6% |
| 93 | ACRS | Aclaris Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $810.3M | 532.0K | 764.0K | 69.6% |
| 94 | ALGN | Align Technology Inc. | Health CareIndustrial Specialties | $10.71B | 284.9K | 409.9K | 69.5% |
| 95 | TARA | Protara Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $224.0M | 121.3K | 174.8K | 69.4% |
| 96 | MDXG | MiMedx Group Inc | Health CareBiotechnology: Pharmaceutical Preparations | $670.5M | 402.9K | 583.0K | 69.1% |
| 97 | ORIC | Oric Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.25B | 224.1K | 324.4K | 69.1% |
| 98 | PFSA | Profusa Inc. | Health CareMedical/Dental Instruments | $1.5M | 94.1K | 136.3K | 69.0% |
| 99 | CGEM | Cullinan Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.35B | 190.6K | 276.6K | 68.9% |
| 100 | TARS | Tarsus Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $3.56B | 97.2K | 141.1K | 68.9% |